Literature DB >> 22104260

HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus.

Anastasia Papadopoulou1, Kristian F Lynch, Eva Anderberg, Mona Landin-Olsson, Ida Hansson, Carl-David Agardh, Åke Lernmark, Kerstin Berntorp.   

Abstract

AIMS: To study HLA-DQB1 genes and islet cell autoantibodies against glutamic acid decarboxylase 65 (GADA) and insulinoma antigen-2 (IA-2A) in relation to diabetes post partum in mothers with diagnosed gestational diabetes mellitus (GDM).
METHODS: During 2003-2004, women undergoing a 75 g oral glucose tolerance test (OGTT) during pregnancy were invited to participate in the Mamma Study. Cut-off level defining GDM was a 2-h capillary blood glucose of 7.8 mmol/L. 1-2 years after delivery a 75 g OGTT was performed, GADA and IA-2A were measured and HLA-DQB1 genes analysed. Data were available for 452 mothers with previous GDM and 168 randomly selected control subjects.
RESULTS: HLA-DQB1*0602 was negatively associated with GDM (p=0.033) and with development of diabetes post partum (p=0.017), whereas high risk HLA were not associated with GDM or with diabetes. The presence of GADA post partum was positively associated with diabetes post partum (p=0.0009), but not with impaired glucose tolerance.
CONCLUSIONS: Mothers with GDM and HLA-DQB1*0602 were less likely to develop diabetes after pregnancy, and type 1 diabetes associated high risk HLA genes did not predict type 1 diabetes post partum. Additionally, GADA were positively associated with diabetes development.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104260     DOI: 10.1016/j.diabres.2011.10.037

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

Review 1.  Maternal outcomes and follow-up after gestational diabetes mellitus.

Authors:  C Kim
Journal:  Diabet Med       Date:  2014-03       Impact factor: 4.359

2.  The relationships between HLA class II alleles and antigens with gestational diabetes mellitus: A meta-analysis.

Authors:  Cong-Cong Guo; Yi-Mei Jin; Kenneth Ka Ho Lee; Guang Yang; Chun-Xia Jing; Xuesong Yang
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

3.  A Case of Stiff Person Syndrome: Immunomodulatory Effect of Benzodiazepines: Successful Rituximab and Tizanidine Therapy.

Authors:  Przemyslaw Zdziarski
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Seasonal Pattern in the Diagnosis of Gestational Diabetes Mellitus in Southern Sweden.

Authors:  Anastasia Katsarou; Rickard Claesson; Claes Ignell; Nael Shaat; Kerstin Berntorp
Journal:  J Diabetes Res       Date:  2016-12-26       Impact factor: 4.011

5.  Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study.

Authors:  Anna-Maaria Auvinen; Kaisu Luiro; Jari Jokelainen; Ilkka Järvelä; Mikael Knip; Juha Auvinen; Juha S Tapanainen
Journal:  Diabetologia       Date:  2020-07-29       Impact factor: 10.122

6.  Testing for type 1 diabetes autoantibodies in gestational diabetes mellitus (GDM): is it clinically useful?

Authors:  Michela Incani; Marco Giorgio Baroni; Efisio Cossu
Journal:  BMC Endocr Disord       Date:  2019-05-03       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.